Podcast: Play in new window | Download
Ant Financial, e-commerce group Alibaba’s financial services affiliate, is reportedly preparing to raise $5bn in funding in a round that will value it at betwen $80bn and $100bn, making it the most valuable VC-backed private company of all time.
Go-Jek has been raising a $1.2bn round over the past six months that already includes JD.com, Tencent, Google and Meituan-Dianping, and now the on-demand ride service is reportedly set to receive up to $290m from e-commerce firm Blibli and industrial conglomerate Astra International in order to increase the round to $1.5bn.
Byton, the smart electric car developer formerly known as Future Mobility, is reportedly in talks with a Chinese state-owned institution to raise between $300m and $400m of funding at a valuation of at least $1.2bn.
Grocery delivery service Instacart is also gearing up to raise funding – up to $250m according to a Delaware securities filing.
Enerkem, a producer of fuels and biochemicals from municipal waste, has raised approximately $224m in its latest round, which included Sinobioway and long-time backer Waste Management of Canada.
Joby Aviation is developing a five-seater electric aircraft that will be able to take off and land vertically, but which is intended to be far quicker than established alternatives like helicopters.
Swiggy is looking to ward off competitors in India’s app-based food delivery sector, such as Zomato and Foodpanda, and has secured $100m in a round led by Naspers Ventures.
Toyota has invested almost $69m in JapanTaxi, a ride hailing app that has signed up about a quarter of Japan’s taxi drivers, as part of a strategic partnership agreement.
AvroBio has raised $60m in a series B round featuring Brace Pharma Capital, the investment firm backed by pharmaceutical company EMS, and will use the proceeds to advance a pipeline of gene therapies for rare diseases.
Broadlink, the China-based developer of a range of connected home products, has secured $54.5m in series D funding from investors including Baidu and Libai. Its past backers include
Qualcomm Ventures, and the company disclosed the funding alongside news that it is preparing an initial public offering in its home country.
Automotive leasing service provider Fair seems like a company on the move. It acquired Uber’s leasing business, Xchange Leasing, last week and has now raised additional funding in a round led by Next47 that included BMW and CreditEase FinTech Investment Fund.
These weren’t the biggest deal on GUV, but they were the most intriguing because it looks as if MIT has spun out two companies that are developing the same technology: Lightmatter, which raised $11m in a series A, and Lightelligence, which secured $10m in a seed round, are developing computer chips that rely on light (or photonic) signals rather than electric signals – boasting orders of magnitude of processing power and having profound implications for data-intensive applications such as AI.
Insurance firm Ping An has emerged as one of the more prominent China-based corporate venturers over the past couple of years and its CVC arm, Ping An Ventures, is now targeting up to $1.3bn in capital for two new funds.
Workday formed its corporate venturing unit, Workday Ventures, in 2015, but the unit has only been sporadically active since. That looks set to change however, with the corporate committing $250m to a Workday Ventures fund that will add AR, VR and blockchain-based enterprise technologies to the AI and machine learning it already targets.
UK-based innovation platform Future Planet Capital has signed a memorandum of understanding with venture capital vehicle Eight Great Technologies Fund (8GT) for an initiative that will invest in British spinouts and companies.
And 4490 Ventures, a US-based venture capital firm co-founded by Wisconsin Alumni Research Foundation (Warf), has raised $49m for its second fund, according to a regulatory filing.
Acacia Pharma, a UK-based nausea and vomiting treatment developer backed by pharmaceutical firms Lundbeck and Novo, has revealed plans for an initial global offering on the Euronext Brussels market. The company has not disclosed how much it expects to raise in the flotation, which will be conducted as a private placement open to certain institutional and other investors outside the US.
Elastagen, an Australia-based dermatology product manufacturer spun out from University of Sydney, today agreed to an acquisition by pharmaceutical firm Allergan for $95m in an upfront payment.
“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0